Everything below concerns pharmacopeial specification. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-08-01. Where a claim depends on a specific study, the study is described rather than over-claimed.
Stability depends on moisture, temperature, and packaging. Dry powders are generally stable for months to years when kept sealed and cool, but heat and humidity can promote clumping, Maillard reactions, and off-flavors. Peptides with lower molecular weight may be more hygroscopic than longer-chain hydrolysates. Light exposure is less critical than moisture control for most commercial powders. Once a container is opened, repeated exposure to air can shorten usable shelf life.
Analytical results are method-dependent, so comparisons across studies require caution. Different molecular weight cutoffs, standards, and calculation models can shift reported averages. Hydroxyproline content is sometimes used as a marker for collagen-derived material, but it does not reveal peptide sequence or biological activity. Regulatory status varies by country and intended use, with some markets treating hydrolyzed collagen as a food ingredient and others as a dietary supplement. Open questions include how to standardize potency and verify claimed peptide profiles.
Regulatory treatment of collagen peptides varies by country and intended use. In the United States, they are typically marketed as dietary supplements or food ingredients, and certain uses may be generally recognized as safe (GRAS) through self-affirmation or notification. In the European Union, collagen peptides from approved animal sources are considered food, not novel foods, if they have a history of consumption. Health claims linking collagen peptides to joint or skin benefits are not approved in the US or EU. Labeling must list the animal source and may state the protein content.
Manufacturing collagen peptides begins with collagen-rich raw materials such as bovine hide, porcine skin, fish scales, or poultry cartilage, which undergo washing, size reduction, and pretreatment to remove non-collagen proteins and fats. Extraction may use acid, alkali, or heat. Hydrolysis then breaks the collagen into smaller peptides, often with enzymes such as pepsin, papain, or alcalase. Process conditions of time, temperature, pH, and enzyme dose determine the final molecular weight distribution. After hydrolysis, the solution is filtered, concentrated, and dried into powder.
| Property | Value | Notes |
|---|---|---|
| Storage temperature | 15–25 °C | Cool, dry conditions reduce moisture uptake and clumping. |
| Relative humidity | Below 60% | High humidity can make powder sticky or caked. |
| Moisture content | Typically below 10% | Lower moisture supports longer shelf life. |
| Analytical method | Size-exclusion chromatography | Used to estimate molecular weight distribution. |
| Shelf life | 24–36 months unopened | Varies with packaging, source, and storage conditions. |
One challenge in collagen peptide analysis is the absence of a single reference standard that covers all possible molecular weight fractions. Products from different sources or hydrolysis conditions yield different peptide profiles, complicating direct comparisons. Some laboratories use gelatin or a defined peptide mixture as a calibration standard, but this approach has limitations. Additionally, the term "collagen peptide" itself lacks a universally accepted molecular weight cutoff. Ongoing discussions aim to establish more consistent definitions and testing protocols for regulatory and research purposes.
Quality control of collagen peptides relies on methods that characterize molecular weight distribution, amino acid composition, and purity. Size exclusion chromatography (SEC) is commonly used to estimate the molecular weight profile of peptide mixtures. High-performance liquid chromatography (HPLC) can separate and quantify individual peptide fractions. Mass spectrometry provides detailed information on peptide sequences and modifications. These techniques help verify that a product meets declared specifications, though standardization across laboratories remains limited.
Commercial collagen peptides come from bovine hide, porcine skin, fish scales, and fish skin. Each source yields a distinct amino acid profile, including different levels of hydroxyproline and glycine. Marine sources often have lower hydroxyproline content than mammalian sources. Production involves extraction, hydrolysis, filtration, and drying, usually spray drying. The final powder is typically white to off-white and dissolves readily in water. Exact composition and peptide size depend on the raw material and the hydrolysis conditions.
Collagen is a structural protein found in skin, bone, tendon, and cartilage, where it forms a triple helix of three polypeptide chains. The chains contain repeating Gly-X-Y sequences, with proline and hydroxyproline frequently occupying the X and Y positions. Collagen peptides are fragments produced by breaking these long chains through hydrolysis. These fragments vary in length and amino acid composition depending on the source and processing method, so the term covers a range of products rather than a single defined molecule.
Hydrolysis converts native collagen into shorter peptides and improves water solubility. Enzymatic treatment with proteases such as pepsin or alkaline proteases is common, though acid or thermal hydrolysis can also be used. The resulting molecular weight distribution typically ranges from about 2 to 10 kilodaltons. Gelatin is a related product formed by partial hydrolysis, but it retains the ability to gel in water. Collagen peptides undergo further breakdown and generally do not form gels.
Collagen peptides are typically sold as a powder that dissolves readily in cold or warm liquids. The powder is usually off-white to light yellow and has a mild taste, though some products may have a slight odor. Molecular weight distributions commonly range from about 1,000 to 5,000 daltons, but this varies by manufacturer and intended use. Smaller peptides are generally more soluble, while larger fragments may form viscous solutions. The material is hygroscopic and should be stored in sealed containers away from moisture and heat.
Collagen peptides are short chains of amino acids produced by hydrolyzing collagen, a structural protein found in skin, bone, and connective tissue. The hydrolysis process breaks the triple-helical collagen molecule into smaller fragments, typically ranging from two to twenty amino acids in length. This reduction in size increases solubility in water and improves absorption compared to intact collagen. The resulting material is a mixture of peptides rather than a single defined compound. Commercial sources include bovine hide, porcine skin, fish scales, and eggshell membrane.
The amino acid profile of collagen peptides is distinctive, with high proportions of glycine, proline, and hydroxyproline. These three residues make up roughly half of the total amino acid content in typical mammalian collagen. Hydroxyproline is formed by post-translational modification of proline and is uncommon in most other proteins. The presence of hydroxyproline serves as a marker for collagen-derived material in analytical testing. Peptide length and distribution depend on the hydrolysis conditions, including temperature, time, and enzyme or acid concentration.
(2026) report evidence from the study of carbon and oxygen stable isotope compositions of mammal fossils from the Pinturas Formation (Argentina) indicative of presence of a diverse range of habitats in Patagonia during the Miocene, and interpret the diversity of the primate assemblage from the studied formation as likely linked to habitat diversity. Cooke et al. (2026) report the first discovery of mandibular remains of Stirtonia victoriae from the La Victoria Formation (Colombia), and interpret their anatomy as indicative of leaf-eating adaptations of the studied monkey. Urciuoli et al. (2026) determine the phylogenetic relationships of early members of Catarrhini on the basis of the study of the semicircular canal and vestibule shape in Saadanius, Pliobates, Ekembo and Victoriapithecus, interpret Saadanius as most likely to be a stem catarrhine that evolved ossified tubular ectotympanic independently from crown catarrhines, and interpret pliopithecoids as most likely to be stem catarrhines closer to the crown group than Saadanius. Arias-Martorell et al. (2026) report evidence of similarities of shape of the radial head of Pliobates cataloniae and extant apes, and interpret Pliobates as better adapted to climbing than to behaviors involving forelimb-dominated suspension. Arias-Martorell et al. (2026) compare the shape of the distal part of the humerus of Pliobates cataloniae and other extinct and extant simians, and interpret Pliobates as unlikely to perform acrobatic suspensory behaviors seen in extant gibbons.
== See also == Alexis St. Martin – Canadian subject of digestion experiments (1802–1880) Fistulated cow M. Ijaiya's technique – Surgical procedure to close juxtacervical vesicovaginal fistulae Obstetric fistula Stoma (medicine)
Abbreviations are used very frequently in medicine, despite being widely discouraged by the Institute of Safe Medicine Practices and other organizations concerned about patient safety. Abbreviations are especially discouraged when healthcare providers are communicating with patients and when there is a possibility of confusion between similar abbreviations. Some facilities maintain a list of acceptable abbreviations. Abbreviations are sometimes specific to a facility, which means that newer staff may be unfamiliar with them; this becomes a potential source of preventable medical errors. The Joint Commission and other organizations maintain lists of certain medical abbreviations that should be avoided to prevent mistakes, according to best practices (and in some cases regulatory requirements); these are flagged in the list of abbreviations used in medical prescriptions.
Two major sources of noise in PET are scatter (a detected pair of photons, at least one of which was deflected from its original path by interaction with matter in the field of view, leading to the pair being assigned to an incorrect LOR) and random events (photons originating from two different annihilation events but incorrectly recorded as a coincidence pair because their arrival at their respective detectors occurred within a coincidence timing window). In practice, considerable pre-processing of the data is required – correction for random coincidences, estimation and subtraction of scattered photons, detector dead-time correction (after the detection of a photon, the detector must "cool down" again) and detector-sensitivity correction (for both inherent detector sensitivity and changes in sensitivity due to angle of incidence). Filtered back projection (FBP) has been frequently used to reconstruct images from the projections. This algorithm has the advantage of being simple while having a low requirement for computing resources. Disadvantages are that shot noise in the raw data is prominent in the reconstructed images, and areas of high tracer uptake tend to form streaks across the image. Also, FBP treats the data deterministically – it does not account for the inherent randomness associated with PET data, thus requiring all the pre-reconstruction corrections described above.
Leroy-Beaulieu was born in Rome. After spending her childhood in Italy where her father, Philippe Leroy, worked in the local film industry, she went to Paris at 16 to study drama against the advice of her parents; her father especially tried to keep her from pursuing a career that followed in his footsteps but was unsuccessful. After appearing on the stage, Leroy-Beaulieu made her screen début in Roger Vadim's 1983 comedy-drama film Surprise Party. The following year, she played Fauve Mistral in the 1984 mini-series version of Judith Krantz's novel Mistral's Daughter. In 1985, Leroy-Beaulieu played her first major screen role (and earned a nomination for the César Award for Most Promising Actress), playing the distraught mother in the Academy Award for Best Foreign Film-nominated comedy Trois hommes et un couffin (Three Men and a Cradle). The success of Coline Serreau's comedy helped her film career and a string of parts in costume films followed such films as Andrzej Wajda's Les Possédés in 1988, Philippe Le Guay's Les Deux Fragonard, and Robert Enrico's and Richard T. Heffron's La Révolution française (Mademoiselle Leroy-Beaulieu acted out the role of Charlotte Corday in the latter production), whose release in 1989 was timed to coincide with celebrations for the bi-centenary of the 1789 Revolution. Leroy-Beaulieu starred in the title role of the French film Natalia, which was screened at the 1988 Cannes Film Festival.
Sources: en.wikipedia.org
=== Sequence-based methods === Prime, NetMHCpan, MHCnuggets, MHCflurry, DeepNeo, and BigMHC are among the most popular methods to predict peptide-MHC immunogenicity from protein amino acid sequences. They essentially parse the protein sequences as text data, using 1-dimensional convolutional neural networks, recurrent neural networks, or Transformer models.
Maybe King Crimson will speak to him in the future in some way, and will revive its head with who-knows-what line up?" At a post-screening Q&A session for In the Court of the Crimson King, Fripp referred to the seven-member 2021 line-up of King Crimson as "the final incarnation" of the band. Asked if there could ever be a line-up that did not include him, he answered negatively, stating "I see the whole. I see the music. I see the musicians. I see the audience and I see the music industry [...] and you have to engage with all of that to have the overview. So that's the quick answer".
This reference follows the "Dieselgate" scandal where Volkswagen and manufacturers around Europe and the world fraudulently concealed their true emissions. In 2007, Commission v Germany held that the German Volkswagen Act 1959 violated free movement of capital in TFEU article 63 by ensuring that the state of Lower Saxony had a golden share to exercise public control over the company's governance. It limited voting rights of individual shareholder to 20% of the company. The German government's justification that the restrictions were an overriding public interest, for instance, to protect workers was rejected. A justification for environmental protection was not offered. After this, the Porsche family dominated Volkswagen, and in 2007 a new CEO, Martin Winterkorn took up his post and aimed in 'Strategie 2018' to become the world's largest auto-manufacturer, and it began to install cheat devices.
== Treatment == Multiple effective therapies are available for the treatment of DM. Standard treatment typically consists of a combination of glucocorticoids and steroid-sparing immunosuppressive agents, including methotrexate, mycophenolate mofetil, azathioprine, tacrolimus, and cyclosporine. Intravenous immunoglobulin (IVIG) has demonstrated efficacy in DM. Although rituximab did not meet its primary endpoint in randomized clinical trials, it remains an important treatment option in clinical practice, particularly for refractory disease, often in combination with IVIG. Janus kinase (JAK) inhibitors, including tofacitinib, ruxolitinib, baricitinib, and brepocitinib, have shown efficacy in dermatomyositis. Additional strategies targeting the type I interferon pathway have also demonstrated benefit, including blockade of interferon-β with dazukibart. Brepocitinib (Lisraya) was approved for medical use in the United States in August 2026. Deep B-cell depletion with CD19 chimeric antigen receptor (CAR) T-cell therapy has shown preliminary evidence of inducing sustained, and potentially treatment-free, remission in DM. Similarly, plasma cell–targeted therapies, including CAR T-cell approaches and monoclonal antibodies, as well as inhibitors of the neonatal Fc receptor (FcRn), such as efgartigimod, have emerged as promising therapeutic strategies for DM. Antimalarial medications, such as hydroxychloroquine, have historically been used to manage the cutaneous manifestations of DM.
==== Dextromethorphan ==== Dextromethorphan/bupropion, sold under the brand name Auvelity, is a combination medication approved by the US FDA in 2022 for the treatment of major depressive disorder (MDD) in adults. The formulation pairs dextromethorphan, an N-methyl-D-aspartate (NMDA) receptor antagonist and sigma-1 receptor agonist, with bupropion, a norepinephrine-dopamine reuptake inhibitor that also functions as a CYP2D6 enzyme inhibitor. Bupropion is included in the combination to slow the metabolism of dextromethorphan by inhibiting CYP2D6, thereby increasing its bioavailability and allowing dextromethorphan's potential antidepressant effects to be achieved. While the precise mechanism of action in treating depression is not fully understood, it is hypothesized that the medication works by modulating glutamate signaling and influencing other neurotransmitter systems.
Sources: en.wikipedia.org
Common methods include protein determination, amino acid analysis, and molecular weight profiling by chromatography or electrophoresis. These tests describe composition and size distribution rather than a single active ingredient. Results can vary with the chosen method and laboratory standards.
Sealed dry powder is usually kept in a cool, dry place away from strong odors and moisture. Higher temperatures and humidity can cause clumping and quality loss. Manufacturers often specify a shelf life under unopened conditions.
Hydrolysis conditions and raw materials produce a range of peptide lengths rather than one uniform size. Analytical methods also give different averages depending on calibration and separation technique. Labels may therefore report a range or an average molecular weight.
Size-exclusion chromatography is the standard method, often with refractive index or ultraviolet detection. Calibration uses known protein standards. SDS-PAGE can provide a rough range but is less precise.